Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Reader Login
Users Online :353
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission


Export selected to
Reference Manager
Medlars Format
RefWorks Format
BibTex Format
  Citation statistics : Table of Contents
   2017| January-March  | Volume 54 | Issue 1  
    Online since December 1, 2017

  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
Related factors of postoperative gallstone formation after distal gastrectomy: A meta-analysis
Y Chen, Y Li
January-March 2017, 54(1):43-46
DOI:10.4103/ijc.IJC_91_17  PMID:29199661
  5 2,398 193
Metformin use and survival of lung cancer patients: Meta-analysis findings
S Zhong, Y Wu, X Yan, J Tang, J Zhao
January-March 2017, 54(1):63-67
DOI:10.4103/0019-509X.219582  PMID:29199666
  5 3,182 255
Robotic resections in hepatobiliary oncology – initial experience with Xi da Vinci system in India
M Chandarana, S Patkar, A Tamhankar, S Garg, M Bhandare, M Goel
January-March 2017, 54(1):52-55
DOI:10.4103/ijc.IJC_132_17  PMID:29199663
  4 2,491 175
Multiple myeloma: Experience of an institute in limited resource setting
Linu Abraham Jacob, MC Suresh Babu, KC Lakshmaiah, K Govind Babu, D Lokanatha, LK Rajeev, KN Lokesh, AH Rudresha, Ankit Agarwal, Sunny Garg
January-March 2017, 54(1):340-342
DOI:10.4103/ijc.IJC_87_17  PMID:29199718
  4 5,482 287
New insights into anaplastic lymphoma kinase-positive nonsmall cell lung cancer
AP Dubey, N Pathi, S Viswanath, A Rathore, A Pathak, R Sud
January-March 2017, 54(1):203-208
DOI:10.4103/ijc.IJC_72_17  PMID:29199691
  3 2,358 190
Nivolumab instills hope in a hopeless situation in advanced nonsmall cell lung cancer with poor performance status
MV Chandrakanth, V Noronha, A Joshi, V Patil, A Mahajan, K Prabhash
January-March 2017, 54(1):55-56
DOI:10.4103/ijc.IJC_10_17  PMID:29199664
  2 2,037 201
Repeat biopsy in epidermal growth factor receptor mutation-positive nonsmall cell lung cancer: Feasibility, limitations, and clinical utility in Indian patients
S Zanwar, V Noronha, A Joshi, VM Patil, A Chougule, R Kumar, S More, S Goud, A Janu, A Mahajan, K Prabhash
January-March 2017, 54(1):280-284
DOI:10.4103/ijc.IJC_215_17  PMID:29199706
  2 1,924 143
Evolving epidemiology of lung cancer in India: Reducing non-small cell lung cancer-not otherwise specified and quantifying tobacco smoke exposure are the key
H Kaur, IS Sehgal, A Bal, N Gupta, D Behera, A Das, N Singh
January-March 2017, 54(1):285-290
DOI:10.4103/ijc.IJC_597_16  PMID:29199707
  2 6,071 403
A prospective study of telephonic contact and subsequent physical follow-up of radically treated lung cancer patients
AS Mathew, JP Agarwal, A Munshi, SG Laskar, CS Pramesh, G Karimundackal, S Jiwnani, K Prabhash, V Noronha, A Joshi, V Rangarajan, NC Purandare, N Jambhekar, S Tandon, A Mahajan, R Kumar, J Deodhar
January-March 2017, 54(1):241-252
DOI:10.4103/0019-509X.219599  PMID:29199699
  2 1,732 135
Chemosuppressive effect of plumbagin on human non-small lung cancer cell xenotransplanted zebrafish
R Vinothkumar, SA Ceasar, A Divyarupa
January-March 2017, 54(1):253-256
DOI:10.4103/0019-509X.219580  PMID:29199700
  2 2,421 135
The increasing challenge of never smokers with adenocarcinoma lung: Need to look beyond tobacco exposure
A Das, A Krishnamurthy, V Ramshankar, TG Sagar, R Swaminathan
January-March 2017, 54(1):172-177
DOI:10.4103/ijc.IJC_33_17  PMID:29199684
  2 3,001 183
Retrospective analysis of icotinib neoadjuvant therapy of 63 lung cancer patients
T Wang, Y Liu, B Zhou, S Hao, Z Wang, N Liang, J Liu, S Wang
January-March 2017, 54(1):215-222
DOI:10.4103/0019-509X.219585  PMID:29199694
  2 2,359 166
A comparative analysis of immunohistochemistry and fluorescent in situ hybridization assay to detect anaplastic lymphoma kinase status in lung adenocarcinoma cases: A search for a testing algorithm
PB Wagle, NA Jambhekar, R Kumar, K Prabhash, CS Pramesh, SB Desai, V Noronha, G Karimundackal, A Shah, A Joshi, SG Laskar, S Jiwnani, T Pai, JP Agarwal
January-March 2017, 54(1):148-154
DOI:10.4103/ijc.IJC_202_17  PMID:29199679
  2 2,281 157
Actual gains in dosimetry and treatment delivery efficiency from volumetric modulated arc radiotherapy for inoperable, locally advanced lung cancer over five-field forward-planned intensity-modulated radiotherapy
RK Shrimali, M Arunsingh, GD Reddy, S Mandal, B Arun, S Prasath, S Sinha, I Mallick, R Achari, S Chatterjee
January-March 2017, 54(1):155-160
DOI:10.4103/ijc.IJC_79_17  PMID:29199680
  2 2,227 116
Lung cancer: Presentation and pattern of care in a cancer center in South India
C Krishnan Nair, AP Mathew, PS George
January-March 2017, 54(1):164-168
DOI:10.4103/ijc.IJC_56_17  PMID:29199682
  2 3,533 183
Predicting loco-regional recurrence risk in T1, T2 breast cancer with 1–3 positive axillary nodes postmastectomy: Development of a predictive nomogram
T Wadasadawala, S Kannan, S Gudi, A Rishi, A Budrukkar, V Parmar, T Shet, S Desai, S Gupta, R Badwe, R Sarin
January-March 2017, 54(1):352-357
DOI:10.4103/ijc.IJC_178_17  PMID:29199721
  2 2,898 203
Epidemiology of gynecological cancers in Kamrup Urban District cancer registry
D Barman, JD Sharma, D Barmon, AC Kataki, A Sharma, M Kalita
January-March 2017, 54(1):388-391
DOI:10.4103/0019-509X.219590  PMID:29199729
  2 3,492 168
Role and relevance of BRAF mutations in risk stratifying patients of papillary thyroid cancers along with a review of literature
A Krishnamurthy, V Ramshankar, K Murherkar, S Vidyarani, GC Raghunandhan, A Das, PB Desai, K Albert
January-March 2017, 54(1):372-378
DOI:10.4103/ijc.IJC_182_17  PMID:29199726
  2 3,161 196
Efficacy and safety of first-line systemic chemotherapy with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil regimens in locally advanced inoperable or metastatic gastric or gastroesophageal junction adenocarcinoma: A prospective phase II study from South India
KG Babu, T Chaudhuri, KC Lakshmaiah, L Dasappa, LA Jacob, MCS Babu, AH Rudresha, KN Lokesh, LK Rajeev
January-March 2017, 54(1):47-51
DOI:10.4103/ijc.IJC_168_17  PMID:29199662
  1 2,418 166
Comparison of paclitaxel-cetuximab chemotherapy versus metronomic chemotherapy consisting of methotrexate and celecoxib as palliative chemotherapy in head and neck cancers
VM Patil, V Noronha, A Joshi, V Agarwala, V Muddu, A Ramaswamy, A Chandrasekharan, S Dhumal, S Juvekar, A Arya, A Bhattacharjee, K Prabhash
January-March 2017, 54(1):20-24
DOI:10.4103/ijc.IJC_160_17  PMID:29199655
  1 2,453 194
Oral health-related quality of life in patients treated for oral malignancy at Kanchipuram district, India: A cross-sectional study
K Indrapriyadharshini, PD Madankumar, GR Karthikeyan
January-March 2017, 54(1):11-15
DOI:10.4103/ijc.IJC_116_17  PMID:29199653
  1 3,535 231
Retrospective analysis of palliative metronomic chemotherapy in head and neck cancer
VM Patil, V Noronha, A Joshi, L Nayak, N Pande, A Chandrashekharan, S Dhumal, A Bhattacharjee, S Banavali, K Prabhash
January-March 2017, 54(1):25-29
DOI:10.4103/ijc.IJC_161_17  PMID:29199656
  1 4,269 269
Anaplastic lymphoma kinase immunohistochemistry in lung adenocarcinomas: Evaluation of performance of standard manual method using D5F3 antibody
D Jain, K Jangra, PS Malik, S Arulselvi, K Madan, S Mathur, MC Sharma
January-March 2017, 54(1):209-213
DOI:10.4103/0019-509X.219588  PMID:29199692
  1 2,110 126
Comparison study of quality of life in advanced lung cancer patients on tyrosine kinase inhibitor and platinum doublet chemotherapy
K Udupa, R Rajendranath, TG Sagar
January-March 2017, 54(1):161-163
DOI:10.4103/0019-509X.219558  PMID:29199681
  1 1,999 137
A meta-analysis: Evaluation of safety and efficacy of the epidermal growth factor receptor-tyrosine kinase inhibitor monotherapy versus platinum-based doublets chemotherapy in East Asia
XF Zhang, LV De-Sheng, M Li, GE Sun, CH Liu
January-March 2017, 54(1):104-114
DOI:10.4103/0019-509X.219586  PMID:29199672
  1 2,240 196
Continuous hyperfractionated accelerated radiotherapy using modern radiotherapy techniques for nonsmall cell lung cancer patients unsuitable for chemoradiation
RK Shrimali, M Arunsingh, A Das, I Mallick, A Mahata, S Prasath, R Achari, S Chatterjee
January-March 2017, 54(1):120-126
DOI:10.4103/ijc.IJC_158_17  PMID:29199674
  1 1,857 111
Effect of tyrosine kinase inhibitors on the glucose levels in diabetic and nondiabetic patients
EY Romero-Ventosa, L Otero-Millán, S González-Costas, P Vilasoa-Boo, A Silva-López, C Arroyo-Conde, G Piñeiro-Corrales
January-March 2017, 54(1):136-143
DOI:10.4103/ijc.IJC_190_17  PMID:29199677
  1 2,756 164
Ceritinib in anaplastic lymphoma kinase-positive nonsmall cell lung cancer among patients who were previously exposed to crizotinib: Experience from the Indian subcontinent
AP Joshi, MV Chandrakanth, V Noronha, V Patil, A Chougule, A Mahajan, AK Janu, R Chanana, K Prabhash
January-March 2017, 54(1):144-147
DOI:10.4103/ijc.IJC_186_17  PMID:29199678
  1 2,164 165
Incidence and characteristics of Epidermal Growth Factor Receptor (EGFR) mutation in non-small-cell lung cancer (Adenocarcinoma histology): A report of 106 patients from Kolkata
K Chatterjee, A Ray, B Chattopadhyay
January-March 2017, 54(1):305-307
DOI:10.4103/ijc.IJC_239_17  PMID:29199710
  1 3,103 197
Mediastinal staging for non-small cell lung cancer revisited. It is being done under aegis of ICON and Lung cancer consortium asia
D Pandey, P Ramanathan, R Pandey, K Prabhash
January-March 2017, 54(1):68-72
DOI:10.4103/0019-509X.219579  PMID:29199667
  1 2,999 212
Is pneumonectomy a justified procedure in patients with persistent N2 nonsmall cell lung cancer disease following induction therapy
S Mitsos, M Petko, D Patrini, M Hayward, M Scarci, D Lawrence, N Panagiotopoulos
January-March 2017, 54(1):73-81
DOI:10.4103/ijc.IJC_209_17  PMID:29199668
  1 2,069 159
Targeted therapy in nonsmall cell lung cancer
T Puri
January-March 2017, 54(1):83-88
DOI:10.4103/ijc.IJC_258_17  PMID:29199670
  1 3,865 311
Histopathological analysis of meningioma and its variants: A study of fifty cases
S Srikanth
January-March 2017, 54(1):313-315
DOI:10.4103/ijc.IJC_119_17  PMID:29199712
  1 1,973 176
Pattern of distant metastasis in molecular subtypes of carcinoma breast: An institutional study
SU Kunikullaya, J Poddar, AD Sharma, S Patel
January-March 2017, 54(1):327-332
DOI:10.4103/ijc.IJC_177_17  PMID:29199716
  1 2,478 211
Tumor characteristics and metabolic quantification in carcinoma breast: An institutional experience
IP Dubey, A Jain, MS Chauhan, R Kumar, S Agarwal, B Kishore, MG Vishnoi, D Paliwal, AR John, N Kumar, A Sharma, AG Pandit
January-March 2017, 54(1):333-339
DOI:10.4103/ijc.IJC_121_17  PMID:29199717
  1 2,256 128
Retrospective study of efficacy and safety of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive locally advanced and oligometastatic breast cancer: An Indian experience
A Tiwari, A Gogia, SVS Deo, NK Shukla, S Mathur, DN Sharma
January-March 2017, 54(1):343-346
DOI:10.4103/ijc.IJC_152_17  PMID:29199719
  1 2,912 269
Venous thromboembolism in cancer patients – magnitude of problem, approach, and management
G Singh, AK Rathi, K Singh, D Sharma
January-March 2017, 54(1):308-312
DOI:10.4103/ijc.IJC_101_17  PMID:29199711
  1 3,607 312
Tuberculosis in epidermal growth factor receptor mutation in lung adenocarcinoma on treatment with gefitinib/erlotinib
D Gothi, S Spalgais
January-March 2017, 54(1):1-1
DOI:10.4103/ijc.IJC_503_16  PMID:29199650
  - 2,423 247
Metastasectomy for recurrent or metastatic biliary tract cancers: A single center experience
I Park, YS Kim, SJ Sym, HK Ahn, KK Kim, YH Park, JN Lee, DB Shin
January-March 2017, 54(1):57-62
DOI:10.4103/0019-509X.219581  PMID:29199665
  - 2,110 122
Comparison of conventional fractionation (five fractions per week) and altered fractionation (six fractions per week) in stage I and II squamous cell carcinoma of oropharynx: An institutional study
J Poddar, AD Sharma, SU Kunikullaya, JP Neema
January-March 2017, 54(1):6-10
DOI:10.4103/ijc.IJC_144_17  PMID:29199652
  - 2,418 154
A study of changes in the oral fungal flora of patients on radiotherapy for head and neck malignancies and their correlation with funguria and fungemia
S Raj, D Sharma, P Mate, MR Capoor, KT Bhowmik
January-March 2017, 54(1):39-42
DOI:10.4103/ijc.IJC_155_17  PMID:29199660
  - 2,645 185
An audit and analysis of different causes of defaults in patients receiving radiation for head and neck cancers: A tertiary regional cancer center experience
L Pujari, S Padhi, P Meher, A Tripathy
January-March 2017, 54(1):31-34
DOI:10.4103/ijc.IJC_114_17  PMID:29199658
  - 1,896 143
Impact of induction chemotherapy to concurrent chemoirradiation over radiotherapy alone in advanced oral cavity
MS Rewadkar, VK Mahobia
January-March 2017, 54(1):16-19
DOI:10.4103/ijc.IJC_166_17  PMID:29199654
  - 2,093 169
Induction chemotherapy in locally advanced T4b oral cavity squamous cell cancers: A regional cancer center experience
AH Rudresha, T Chaudhuri, KC Lakshmaiah, KG Babu, L Dasappa, LA Jacob, MC Suresh Babu, KN Lokesh, LK Rajeev
January-March 2017, 54(1):35-38
DOI:10.4103/ijc.IJC_131_17  PMID:29199659
  - 2,467 157
Is pulmonary metastasectomy beneficial in head and neck squamous cell carcinoma? A review of literature
NR Subramaniam, R Reddy, D Balasubramanian, K Thankappan, S Iyer
January-March 2017, 54(1):2-5
DOI:10.4103/ijc.IJC_170_17  PMID:29199651
  - 2,941 231
Atypical lung carcinoid: An unusual presentation
MM Mohapatra, RC Mulkoju, J Joseph, D Gochhait
January-March 2017, 54(1):213-214
DOI:10.4103/ijc.IJC_150_17  PMID:29199693
  - 1,693 103
Practical solutions to epidermal growth factor receptor tyrosine kinase inhibitor dose modifications in resource-constrained settings: Thinking outside the (packaging) box
N Singh, KT Prasad
January-March 2017, 54(1):186-187
DOI:10.4103/0019-509X.219576  PMID:29199687
  - 1,374 77
Sister Mary Joseph's nodule: Two rare cases of inoperable gallbladder cancer
AK Jha, SK Jha, R Kumar, U Kumar
January-March 2017, 54(1):29-30
DOI:10.4103/ijc.IJC_135_17  PMID:29199657
  - 1,880 111
Expanded panel test detecting mesenchymal-epithelial transition amplification leading to effective treatment in adenocarcinoma lung
VM Noronha, S Jandyal, A Joshi, VM Patil, A Mahajan, K Prabhash
January-March 2017, 54(1):325-326
DOI:10.4103/0019-509X.219596  PMID:29199715
  - 1,266 91
Chemo port insertion through femoral vein approach: A rare indication and a rare complication
SG Dholaria, D Yadav, AK Gupta
January-March 2017, 54(1):361-361
DOI:10.4103/ijc.IJC_193_17  PMID:29199723
  - 2,586 124
Fluorodeoxyglucose-avid pulmonary mucinous adenocarcinoma presenting with nonfluorodeoxyglucose-avid cystic brain lesions of unknown etiopathology: Brain magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography-computed tomography imaging features and additional value of whole-body positron emission tomography acquisition
V Shinde, S Basu
January-March 2017, 54(1):81-82
DOI:10.4103/0019-509X.219578  PMID:29199669
  - 1,360 104
The single-incision versus multiple-incision video-assisted thoracoscopic surgery in the treatment of lung cancer: A systematic review and meta-analysis
X Zhang, Q Yu, D Lv
January-March 2017, 54(1):291-300
DOI:10.4103/ijc.IJC_229_17  PMID:29199708
  - 2,841 218
Stereotactic body radiation therapy for early-stage primary lung cancer, is an active breath coordinator necessary? An audit from a tertiary cancer care center
R Madhavan, PS Renilmon, HM Nair, A Lal, SS Nair, UG Unnikrishnan, D Makuny
January-March 2017, 54(1):301-304
DOI:10.4103/ijc.IJC_230_17  PMID:29199709
  - 1,740 87
Study of gefitinib maintenance in unselected patients with metastatic primary lung adenocarcinoma: A descriptive study
R Kumar, B Dubashi, S Kayal, SC Lazzar, D Barathi, V Kumar
January-March 2017, 54(1):188-192
DOI:10.4103/ijc.IJC_46_17  PMID:29199688
  - 1,949 135
Clinical profile of nonsmall cell lung carcinoma patients treated in a single unit at a tertiary cancer care center
DC Doval, R Sinha, U Batra, KD Choudhury, S Azam, A Mehta
January-March 2017, 54(1):193-196
DOI:10.4103/0019-509X.219591  PMID:29199689
  - 2,319 163
Clinical profile and outcomes of patients with Stage IV adenocarcinoma of lung: A tertiary cancer center experience
P Paliwal, S Rajappa, A Santa, MVTK Mohan, S Murthy, N Lavanya
January-March 2017, 54(1):197-202
DOI:10.4103/0019-509X.219595  PMID:29199690
  - 2,689 191
Gemcitabine and carboplatin in metastatic nonsmall cell lung cancer: Experience from a tertiary cancer center in South India
T Devika, B Dubashi, DG Shewade, S Kayal, RCS Kumar
January-March 2017, 54(1):169-171
DOI:10.4103/ijc.IJC_28_17  PMID:29199683
  - 1,828 117
The comparison of thoracoscopic-laparoscopic esophagectomy and open esophagectomy: A meta-analysis
B Wang, Z Zuo, H Chen, B Qiu, M Du, Y Gao
January-March 2017, 54(1):115-119
DOI:10.4103/ijc.IJC_192_17  PMID:29199673
  - 2,500 165
Development and validation of a predictive score, for identifying poor eastern cooperative oncology group performance status (performance status 3–4) advanced nonsmall cell lung cancer patients who are likely to benefit from tyrosine kinase inhibitors
A Joshi, A Bhattacharjee, V Noronha, VM Patil, A Karpe, N Kadam, L Solanki, K Prabhash
January-March 2017, 54(1):127-131
DOI:10.4103/ijc.IJC_162_17  PMID:29199675
  - 1,901 108
Epidermal growth factor receptor positive lung cancer: The nontrial scenario
V Noronha, VM Patil, A Joshi, N Tandon, V Sharma, A Ramaswamy, SB More, S Gaud, K Prabhash
January-March 2017, 54(1):132-135
DOI:10.4103/0019-509X.219583  PMID:29199676
  - 1,743 122
Demographic, clinical, biochemical, radiological and etiological characteristics of malignant pleural effusions from Eastern India
K Saha, MK Maikap, A Maji, M Moitra, D Jash
January-March 2017, 54(1):257-261
DOI:10.4103/0019-509X.219575  PMID:29199701
  - 2,685 157
Palliative thoracic radiotherapy in advanced lung cancer: A single institution experience
C Hotwani, JP Agarwal, K Prabhash, A Munshi, A Joshi, S Misra, D Kumar, S Das, SG Laskar
January-March 2017, 54(1):262-266
DOI:10.4103/0019-509X.219587  PMID:29199702
  - 2,020 111
Metastatic nonsmall cell lung cancer in South India: A regional demographic study
KC Lakshmaiah, MP Kamath, KG Babu, U Amirtham, D Loknatha, AS Komaranchath
January-March 2017, 54(1):267-270
DOI:10.4103/0019-509X.219566  PMID:29199703
  - 1,930 123
Solitary pulmonary nodule evaluation in regions endemic for infectious diseases: Do regional variations impact the effectiveness of fluorodeoxyglucose positron emission tomography/computed tomography
NC Purandare, CS Pramesh, JP Agarwal, A Agrawal, S Shah, K Prabhash, G Karimundackal, S Jiwnani, S Tandon, V Rangarajan
January-March 2017, 54(1):271-275
DOI:10.4103/0019-509X.219563  PMID:29199704
  - 2,279 180
Outcomes in lung cancer: An experience from routine tertiary care setting
R Thippeswamy, S Patil, P Prashanth, CT Sateesh, T Vittal, HP Shashidhara, KM Haridas
January-March 2017, 54(1):276-279
DOI:10.4103/0019-509X.219606  PMID:29199705
  - 1,932 136
Role of crizotinib in c-mesenchymal-epidermal transition-positive nonsmall cell lung cancer patients
U Batra, A Jain, M Sharma, R Bajaj, M Suryavanshis
January-March 2017, 54(1):178-181
DOI:10.4103/0019-509X.219592  PMID:29199685
  - 2,084 133
First-line therapy outcomes in patients with advanced stage nonsmall cell lung cancer treated at nongovernment tertiary care centrer in India: Experience from a real world practice
SS Hingmire, MB Sambhus, DS Kelkar, SW Joshi, KS Narsinghpura
January-March 2017, 54(1):182-186
DOI:10.4103/0019-509X.219594  PMID:29199686
  - 1,727 147
The efficacy and safety of preoperative chemotherapy for patients with nonsmall cell lung cancer: A meta-analysis
T Wang, T Yan, S Ma, K Wang, J Wang, J Song, W He, J Bai, L Jin
January-March 2017, 54(1):223-227
DOI:10.4103/ijc.IJC_60_17  PMID:29199695
  - 1,812 112
Dual mutations and complex mutations in metastatic nonsmall cell lung cancer: A single-institution experience from South India
L Kadabur, D Koppaka, GB Kanakasetty, A Usha, LC Kuntegowdanahalli, L Dasappa, LA Jacob, SMC Babu, RA Haleshappa, A Abhishek, LK Rajeev
January-March 2017, 54(1):228-230
DOI:10.4103/ijc.IJC_20_17  PMID:29199696
  - 1,622 109
Anaplastic lymphoma kinase status in lung cancers: An immunohistochemistry and fluorescence in situ hybridization study from a tertiary cancer center in India
SS Murthy, SJ Rajappa, SD Gundimeda, KM Mallavarapu, S Ayyagari, P Yalavarthi, D Fonseca, P Paliwal, HGR Nair, V Koppula, KVVN Raju, ST Rao
January-March 2017, 54(1):231-235
DOI:10.4103/0019-509X.219533  PMID:29199697
  - 2,088 152
Role of pneumonectomy for lung cancer in current scenario: An Indian perspective
SH Shah, A Goel, VPP Selvakumar, S Garg, K Siddiqui, K Kumar
January-March 2017, 54(1):236-240
DOI:10.4103/0019-509X.219569  PMID:29199698
  - 2,282 129
Indian consensus statement for treatment of advanced non small cell lung cancer: First line, maintenance, and second line
Under the aegis of Lung Cancer Consortium Asia (LCCA) , Indian Cooperative Oncology Network (ICON) , Indian Society of Medical & Pediatric Oncology (ISMPO) , Molecular Oncology Society (MOS) and Association of Physicians of India API)
January-March 2017, 54(1):89-103
DOI:10.4103/ijc.IJC_136_17  PMID:29199671
  - 5,275 428
Stereotactic body radiation therapy for hepatocellular carcinoma: Experience from a tertiary cancer care center in India
R Madhavan, B Kunher, M Arunlal, HM Nair, UG Unnikrishnan, R Holla, D Makuny
January-March 2017, 54(1):316-320
DOI:10.4103/ijc.IJC_156_17  PMID:29199713
  - 1,946 158
Prognostic factors and treatment of patients with advanced synovial sarcoma: A single-center experience
O Ates, S Aksoy, H Yeter, V Sunar, N Kertmen, O Dizdar, A Turker, A Kars
January-March 2017, 54(1):321-325
DOI:10.4103/ijc.IJC_169_17  PMID:29199714
  - 2,327 176
A prospective randomized trial comparing capecitabine-based chemoradiotherapy with 5-FU-based chemoradiotherapy in neoadjuvant setting in locally advanced carcinoma rectum
K Singh, MK Gupta, RK Seam, M Gupta
January-March 2017, 54(1):347-351
DOI:10.4103/ijc.IJC_174_17  PMID:29199720
  - 2,153 174
Composite lymphomas: Experience from a tertiary cancer center in Kerala, South India
JA Vasudevan, RA Nair, R Sukumaran, SG Nair
January-March 2017, 54(1):358-361
DOI:10.4103/ijc.IJC_89_17  PMID:29199722
  - 1,942 118
Survival and prognostic factors for glioblastoma multiforme: Retrospective single-institutional study
M Ghosh, S Shubham, K Mandal, V Trivedi, R Chauhan, S Naseera
January-March 2017, 54(1):362-367
DOI:10.4103/ijc.IJC_157_17  PMID:29199724
  - 10,123 286
Rechallenge temozolomide in glioma: A case series from India
VM Patil, R Tonse, R Kothari, A Chandrasekaran, N Pande, S Epari, T Gupta, R Jalali
January-March 2017, 54(1):368-371
DOI:10.4103/ijc.IJC_173_17  PMID:29199725
  - 1,903 122
Evaluation of dose conformity and coverage of target volume for intensity-modulated radiotherapy of pelvic cancer treatment
M Atiq, A Atiq, K Iqbal, Q Shamsi, F Andleeb, SA Buzdar
January-March 2017, 54(1):379-384
DOI:10.4103/ijc.IJC_80_17  PMID:29199727
  - 4,383 120
Testicular seminoma: Are clinical features and treatment outcomes any different in India?
M Anjanappa, A Kumar, S Mathews, J Joseph, KM Jagathnathkrishna, FV James
January-March 2017, 54(1):385-387
DOI:10.4103/ijc.IJC_100_17  PMID:29199728
  - 3,166 147
  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow